Therapeutic Areas

Performance Metrics

Number of Studies Conducted: 150Number of Active Patients in the Database: 10,000Average Percent of Total Patients Randomized: 70%Average Percent of ‘Completed’ Studies that met Enrollment Goals: 90%EDC Capabilities: Yes

Staff CertificationsNumber of Certified CRCs: 4

ACRP CertificationsNumber of ACRP Certified CRCs: 4

Overview

Located on the campus of St. Luke’s Hospital, The Lung Research Center has conducted clinical trials for the treatment of complex lung disease for over 20 years. We have stayed true to our original mission to offer our patients access to new treatments currently under investigation and not ordinarily available. Our work focuses on COPD, Asthma, Bronchiectasis, and Pulmonary Hypertension with a particular emphasis on Idiopathic Pulmonary Fibrosis (IPF), a deadly disease which until recently had no treatment. We are committed to bringing the latest developments in the treatment of lung disease to our patients and the physicians who care for them.

Experience

The Lung Research Center has over two decades of experience in the following areas:

COPD

Idiopathic Pulmonary Fibrosis

Asthma

Brochiectasis

Pulmonary Embolism/DVT

Pulmonary Hypertension

Chronic Cough

Facility

The Lung Research Center is a private research facility located in the north medical building on the campus of St. Luke’s Hospital. We have all the necessary equipment to perform phase II- IV clinical trials. We have 3 exam rooms, a spacious patient waiting room, a private monitoring area and a locked storage space for study records and medications. In addition we are equipped with ECG machines, nebulizers, spirometer, an emergency cart, and oxygen. Our research facility also has drug storage refrigerators, a - 20 and - 80 degree Celsius freezers, and a refrigerated & ambient centrifuge. The adjacent hospital has full radiology facilities, a pulmonary function lab and infusion services.

Investigator

Neil Ettinger, MD

Andrew Labelle, MD

Neil Ettinger, MD is board certified in Internal Medicine, Pulmonary Disease, Sleep Medicine and Critical Care Medicine. He is a member of the American College of Physicians, American College of Chest Physicians, American Thoracic Society, American Sleep Disorders Association, and American Association of Bronchology. Dr. Ettinger has over two decades of clinical research experience conducting phase II-IV clinical trials. He has been a principal investigator since 1994 on over 100 clinical trials.

Andrew Labelle, MD is board certified in Internal Medicine and Pulmonary Disease and a member of the American College of Physicians, American Thoracic Society, American College of Chest Physicians, and Society of Critical Care Medicine. He has served as principal investigator on multiple clinical trials focusing on asthma, COPD and pulmonary fibrosis.

Staff

Our staff of highly trained professionals has over 40 years of combined clinical trial experience. All members of our research team are active members of the Association of Clinical Research Professionals and are extensively trained in good clinical practice and patient care.

Patients

The Lung Research Center is located in the St. Louis Metropolitan area. The metropolitan area is the 20th largest in the United States with a population of 2.8 million. The bi-state metropolitan area includes seven counties in Missouri and eight in Illinois.